Abstract:Background: Long non-coding RNA LINC00319 has been implicated in the progression of various cancers, including oral squamous cell carcinoma (OSCC). While our previous work has revealed some aspects of LINC00319's role in OSCC, including its upregulation and involvement in a competing endogenous RNA (ceRNA) mechanism, the full extent of its functions and regulatory mechanisms in OSCC progression remain to be fully elucidated. Objective: This study aimed to investigate the function of LINC00319 in OSCC and its potential interaction with the STAT3 signaling pathway, thus uncovering novel regulatory mechanisms and therapeutic targets. Methods: Bioinformatics analysis was performed using TCGA data to evaluate LINC00319 expression in OSCC tissues and its correlation with STAT3 signaling. The direct binding between LINC00319 and STAT3 was examined by RNA pull-down, FISH, and RIP assays. Functional experiments, including CCK-8, transwell migration and invasion assays, and western blot analysis of EMT markers and STAT3 pathway activation, were conducted to assess the effects of LINC00319 on OSCC cell behaviors and its interaction with the STAT3 signaling pathway. In vivo xenograft models were established to validate the role of LINC00319 in tumor growth and STAT3 activation. Results: LINC00319 expression was significantly upregulated in OSCC tissues compared to normal tissues, and high LINC00319 expression correlated with STAT3 signaling activation. Mechanistically, LINC00319 directly bound to STAT3 protein and promoted its phosphorylation at Tyr705. LINC00319 overexpression enhanced, while its knockdown suppressed, the proliferation, migration, invasion, and EMT of OSCC cells. These oncogenic effects were mediated through STAT3 activation and could be reversed by the STAT3 inhibitor stattic. In vivo experiments further confirmed that LINC00319 silencing inhibited tumor growth and STAT3 phosphorylation. Conclusion: This study uncovers that LINC00319 promotes OSCC tumorigenesis by directly binding to and activating STAT3 signaling. These findings provide new insights into the regulatory mechanisms of STAT3 by long non-coding RNAs and highlight the potential of LINC00319 as a biomarker and therapeutic target in OSCC.

SLC2A3 promotes tumor progression through lactic acid-promoted TGF-β signaling pathway in oral squamous cell carcinoma

Downregulation of SLC3A2 mediates immune evasion and accelerates metastasis in oral squamous cell carcinoma

The LINC00319 binding to STAT3 promotes the cell proliferation, migration, invasion and EMT process in oral squamous cell carcinoma

FSCN1 promotes proliferation, invasion and glycolysis via the IRF4/AKT signaling pathway in oral squamous cell carcinoma

Increased LGALS3BP Promotes Proliferation and Migration of Oral Squamous Cell Carcinoma Via PI3K/AKT Pathway

SLC3A2 is Upregulated in Human Osteosarcoma and Promotes Tumor Growth Through the PI3K/Akt Signaling Pathway.

Stromal-epithelial Lactate Shuttle Induced by Tumor‑derived Interleukin‑1β Promotes Cell Proliferation in Oral Squamous Cell Carcinoma.

SLCO1B3 promotes colorectal cancer tumorigenesis and metastasis through STAT3

Defect of SLC38A3 Promotes Epithelial-Mesenchymal Transition and Predicts Poor Prognosis in Esophageal Squamous Cell Carcinoma.

SLC6A8 is involved in the progression of non-small cell lung cancer through the Notch signaling pathway

LINC00035 Transcriptional Regulation of SLC16A3 via CEBPB Affects Glycolysis and Cell Apoptosis in Ovarian Cancer

LDHA Promotes Oral Squamous Cell Carcinoma Progression Through Facilitating Glycolysis and Epithelial–Mesenchymal Transition

Long non-coding RNA SLC2A1-AS1 induced by GLI3 promotes aerobic glycolysis and progression in esophageal squamous cell carcinoma by sponging miR-378a-3p to enhance Glut1 expression

METTL3 Promotes Oral Squamous Cell Carcinoma Progression by Enhancing SLC7A11 mRNA Stability via m6A-Mediated IGF2BP2 Binding

SLC9A2, Suppressing by the Transcription Suppressor ETS1, Restrains Growth and Invasion of Osteosarcoma Via Inhibition of Aerobic Glycolysis.

Long Non-Coding RNA SLC16A1-AS1: Its Multiple Tumorigenesis Features and Regulatory Role in Cell Cycle in Oral Squamous Cell Carcinoma

Increased expression of lncRNA CASC9 promotes tumor progression by suppressing autophagy-mediated cell apoptosis via the AKT/mTOR pathway in oral squamous cell carcinoma

Chemokine (CC Motif) Ligand 18 Upregulates Slug Expression to Promote Stem-Cell Like Features by Activating the Mammalian Target of Rapamycin Pathway in Oral Squamous Cell Carcinoma.

TRIB3 promotes the growth of oral squamous cell carcinoma by regulating JNK/JUN-mediated aerobic glycolysis

The sodium/myo-inositol co-transporter SLC5A3 promotes non-small cell lung cancer cell growth

TGFβ1‐Smad3‐Jagged1‐Notch1–Slug Signaling Pathway Takes Part in Tumorigenesis and Progress of Tongue Squamous Cell Carcinoma